RANTES production in HIV-1 antigen-stimulated whole blood culture: Relationship with type 1 immune response and plasma viral load in individuals infected with HIV-1

Scandinavian Journal of Immunology

Volumn 48, Issue 2, 1998, Pages 212-216

  Benyoucef, S ^a   Hober, D ^a,d   De Groote, D ^b   Bocket, L ^a   De La Tribonniere X ^c   Mouton, Y ^c   Wattre P ^a  

^a Laboratoire de Virologie Institut Gernez Rieux   (France)

^b BioSource Europe SA   (Belgium)

^c CENTRE HOSPITALIER DE TOURCOING   (France)

^d CHU Rouen BG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RANTES;

ANTIBODY PRODUCTION; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MEDIATOR RELEASE; MITOGENICITY; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-4; RANTES; RNA, VIRAL; VIRAL LOAD;

EID: 0031867081     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00382.x     Document Type: Article

References (23)

1. Clerici M, Ballota C, Salvaggio A et al. Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 1996;88:574-9.
2. Clerici M, Ballota C, Meroni L et al. Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. AIDS Res Hum Retroviruses 1996;12: 1053-61.
3. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994;8:757-62.
4. + T cells. Science 1995; 270:1811-5.
5. Clerici M, Balotta C, Trabattoni D et al. Chemokine production in HTV-seropositive long-term asymptomatic individuals. AIDS 1996; 10:1432-3.
6. + cells in HIV infection produce macrophage inflammatory protein-1α and RANTES: a comparative study in long term survivors and progressor patients. Immunol Lett 1996;53:1005-8.
7. Center for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993; 1-19.
8. De Groote D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239-48.
9. Benyoucef S, Hober D, De Groote D et al An interferon-γ (IFN-γ) based whole blood assay to detect T cell response to antigens in HIV-1 infected patients. Pathol Biol 1997;45:400-3.
10. Hober D, Lucas B, Wattré P, Capron A, Haque A. TNF-α production by U937 promonocytes is enhanced by factors released from HIV-infected T lymphocytes: TNF-α is one of the mediators causing HIV-infected T4 cells lysis. Clin Immunol Immunopathol 1992; 62:168-75.
11. Leroux M, Schindler L, Braun R, Doerr HW, Geisen HP, Kirchner H. A whole blood lymphoproliferation assay for measuring cellular immunity against herpes viruses. J Immunol Meth 1985;79:251-62.
12. Fiavey NP, Frankenberg S. Appraisal of the total blood lymphocyte proliferation assay as a diagnostic tool in screening for tuberculosis. J Med Microbiol 1992;37:283-5.
13. Weir RE, Morgan AR, Britton WJ, Butlin CR, Dockrell HM. Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno- epidemiological field studies of leprosy immunity. J Immunol Meth 1994;176:93-101.
14. Goudsmit J, De Wolf F, Paul DA et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 1986;2:177-9.
15. Allain JP, Laurian A, Paul DA, Senn D. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet 1986;2:1233-5.
16. Spector SA, Kennedy C, McCutchan A et al. The macrophage in the persistence and pathogenesis of HIV infection. AIDS 1989;3: 475-96.
17. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 immune response. J Immunol 1996;157:3598-604.
18. Devergne O, Marfaing-Koka A, Schall TT et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994;179:1689-94.
19. Jassoy C, Harrer T, Rosenthal T et al. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor (TNF-α). and TNF-β when they encounter their target antigens. J Virol 1993;67:2844-52.
20. Oppenheim JJ, Zachariae CO, Mukadai N, Matsushima K. Properties of the novel pro-inflammatory supergene 'intercrine' cytokine family. Anu Rev Immunol 1991;9:617-48.
21. Zanussi S, D'Andrea M, Simonelli C, Tirelli U, De Paoli P. Serum levels of RANTES and MIP-1α in HIV-positive long-term survivors and progressor patients. AIDS 1996;10:1431-2.
22. McKenzie SW, Dullalio G, North M, Frame P, Means RT. Serum chemokines levels in patients with non-progressing HIV infection. AIDS 1996;10:F29-F33.
23. Krowka JF, Gesner ML, Ascher MS, Sheppard HW. Lack of association of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals. Clin Immunol Immunopathol 1997;85:21-7.